SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Holding(s) in Company

26 Aug 2021 17:00

RNS Number : 9362J
BioPharma Credit PLC
26 August 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDGKMY29

Issuer Name

BIOPHARMA CREDIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

M&G Plc

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

25-Aug-2021

6. Date on which Issuer notified

26-Aug-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.016240

0.021840

5.038080

69216692

Position of previous notification (if applicable)

4.956520

0.081560

5.038080

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BDGKMY29

0

68916692

0.000000

5.016240

Sub Total 8.A

68916692

5.016240%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

GB00BDGKMY29 (Right of Recall)

300000

0.021840

Sub Total 8.B1

300000

0.021840%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

M&G Plc

M&G Plc (Parent company)

5.016240

0.021840

5.038080

M&G Plc

M&G Group Regulated Entity Holding Company Limited (wholly owned subsidiary of M&G Plc)

4.870490

0.021840

4.892330

M&G Plc

M&G Group Limited (wholly owned subsidiary of M&G Group Regulated Entity Holding Company Limited)

4.870490

0.021840

4.892330

M&G Plc

M&G FA Limited (wholly owned subsidiary of M&G Group Limited)

4.870490

0.021840

4.892330

M&G Plc

M&G Investment Management Limited (wholly owned subsidiary of M&G FA Limited)

4.870490

0.021840

4.892330

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

26-Aug-2021

13. Place Of Completion

London, England

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUNUVRAVUWUAR
Date   Source Headline
9th Jun 20268:00 amRNSNEW INVESTMENT
3rd Jun 202611:40 amRNSNew Investment
1st Jun 20264:51 pmRNSDirector/PDMR Shareholding
1st Jun 20261:39 pmRNSTotal Voting Rights
26th May 20266:15 pmRNSTransaction in Own Shares
22nd May 20266:15 pmRNSTransaction in Own Shares
22nd May 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st May 20266:15 pmRNSTransaction in Own Shares
20th May 20266:15 pmRNSTransaction in Own Shares
15th May 20266:15 pmRNSTransaction in Own Shares
6th May 20265:47 pmRNSTransaction in Own Shares
6th May 20267:00 amRNSSTATEMENT RE ALPHATEC PREPAYMENT
6th May 20267:00 amRNSNotice of AGM
5th May 20267:00 amRNSStatement re ARCHIMED
1st May 202612:09 pmRNSTotal Voting Rights
29th Apr 20266:15 pmRNSTransaction in Own Shares
29th Apr 20265:03 pmRNSHolding(s) in Company
27th Apr 20266:15 pmRNSTransaction in Own Shares
24th Apr 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Apr 20264:10 pmRNSDividend Declaration
16th Apr 20265:59 pmRNSDirector/PDMR Shareholding
14th Apr 20265:44 pmRNSTransaction in Own Shares
13th Apr 20265:07 pmRNSTransaction in Own Shares
10th Apr 20265:36 pmRNSTransaction in Own Shares
10th Apr 20267:00 amRNSInvestor Presentation via Investor Meet Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20266:15 pmRNSTransaction in Own Shares
25th Mar 20266:23 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSAnnual Financial Report
20th Mar 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Mar 202611:26 amRNSUPDATE ON INVESTMENT PORTFOLIO
17th Mar 20267:00 amRNSNEW INVESTMENT OF US$125 MILLION
17th Mar 20267:00 amRNSNEW INVESTMENT OF US$125 MILLION
2nd Mar 20261:39 pmRNSUPDATE ON INVESTMENT
20th Feb 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Feb 20265:20 pmRNSDividend Declaration
3rd Feb 20267:00 amRNSNotice of Full Year Results
23rd Jan 20264:00 pmRNSNet Asset Value(s) and Monthly Factsheet
30th Dec 20251:32 pmRNSSTATEMENT RE COLLEGIUM PREPAYMENT
30th Dec 20251:32 pmRNSSTATEMENT RE COLLEGIUM PREPAYMENT
19th Dec 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Nov 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
4th Nov 20253:29 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Oct 20257:00 amRNSUPDATES ON INVESTMENT PORTFOLIO
7th Oct 20257:00 amRNSNEW INVESTMENT OF US$30 MILLION
23rd Sep 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Sep 20257:00 amRNSHalf-year Report
18th Sep 20255:15 pmRNSDividend Declaration
3rd Sep 202512:21 pmRNSNEW INVESTMENT OF UP TO US$62.5 MILLION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.